MSA MSA Safety (MSA) Insider Trading, Ownership & Congress Trades
Medical Devices · Orthopedic, prosthetic & surgical appliances & supplies · CIK 0000066570
C-suite buying · 1Form 144 · 2
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
240
13F, latest reported quarter
What the filings say about MSA
Insiders, 180 days
-$3.9M net sold
1 buyer · 2 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$4.5M
2 notices
MSA Safety insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, MSA Safety Inc insiders sold a net $3.9M of stock across 62 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 14 earlier Form 4 trades (code P or S) here by this insider (14 sales), the last on May 13, 2025.
- The trade is 39.7% of the 50,324 shares held after it.
- 1 other insider sold within 30 days.
- 240 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Vartanian Nishan J. sold about $3.9M of MSA on Aug 7, 2026, the largest insider sale at the company since 2025; 1 other insider sold within 30 days and 240 funds added in the latest 13F quarter.Context
- 7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on Feb 17, 2026.
- The trade is 12.4% of the 3,776 shares held after it.
- 1 other insider sold within 30 days.
- 240 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Accounting Officer Buck Jonathan D. sold about $89.6K of MSA on Aug 4, 2026; 1 other insider sold within 30 days and 240 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 11.7% of the 3,825 shares held after it.
- No other insider bought within 30 days.
- 240 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer BECK JULIE A bought about $71.1K of MSA on Jun 11, 2026, the largest insider purchase at the company on our record; 240 funds added in the latest 13F quarter.Context
- 6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Nov 25, 2025.
- The trade is 34.0% of the 3,234 shares held after it.
- No other insider sold within 30 days.
- 240 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Accounting Officer Buck Jonathan D. sold about $223.8K of MSA on Feb 17, 2026; 240 funds added in the latest 13F quarter.Context
- 5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Feb 24, 2025.
- The trade is 7.5% of the 4,434 shares held after it.
- No other insider sold within 30 days.
- 240 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Accounting Officer Buck Jonathan D. sold about $53.6K of MSA on Nov 25, 2025; 240 funds added in the latest 13F quarter.62 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$3.9M over 180 days
-$4.0M over 90 days
below 74% of Medical Devices
Congress
no House purchase disclosed in the last 12 months
Funds
240 funds bought in last quarter
more than 86% of Medical Devices
Revenue
+3.7% year over year
below 70% of Medical Devices
Margin
14.9% net margin
more than 88% of Medical Devices
Buybacks
no share repurchases reported
Short interest
3.1% of the float short (float per yahoo 2026-10-27) · 5.0 days to cover · settled 2026-10-15
below 53% of Medical Devices
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch MSA
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+10.8%12M
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns MSA: institutional holders (13F)
13F holdings, latest reported quarter
3,331,741 sh
$581.7M
1,828,682 sh
$319.3M
1,721,415 sh
$300.5M
1,708,900 sh
$298.3M
1,626,476 sh
$283.8M
Congress trades in MSA
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
MSA planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Howells David J
Filed 2026-08-18
$645.6K
NISHAN J VARTANIAN
Filed 2026-08-07
$3.9M
MSA mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
SouthernSun Small Cap Fund
$12.0M position · as of 2026-06-30
4.7%
SouthernSun U.S. Equity Fund
$2.0M position · as of 2026-06-30
3.9%
Madison Mid Cap Fund
$58.5M position · as of 2026-07-31
3.4%
FMI Common Stock Fund
$62.8M position · as of 2026-06-30
3.3%
Sequoia Fund Inc
$117.4M position · as of 2026-06-30
3.2%
Mid Cap Fund
$3.2M position · as of 2026-06-30
3.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $3.9M sold by insiders over 180 days, 240 funds added last quarter, $4.5M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
MSA financials
Revenue growth
+3.7%
XBRL, annual
Net margin
14.9%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.9B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM MSA
| FY Dec 2025 | $1.9B |
| FY Dec 2024 | $1.8B |
| FY Dec 2023 | $1.8B |
| FY Dec 2022 | $1.5B |
| FY Dec 2021 | $1.4B |
| Jun 2026 | $503.3M |
| Mar 2026 | $463.6M |
| Dec 2025 | $510.9M |
| Sep 2025 | $468.4M |
| Jun 2025 | $474.1M |
| Mar 2025 | $421.3M |
| Dec 2024 | $499.7M |
| Sep 2024 | $432.7M |
At each fiscal year end
Single quarter
Net margin, TTM
+16.1%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM MSA
| FY Dec 2025 | +14.9% |
| FY Dec 2024 | +15.8% |
| FY Dec 2023 | +3.3% |
| FY Dec 2022 | +11.8% |
| FY Dec 2021 | +1.5% |
| Jun 2026 | +17.1% |
| Mar 2026 | +15.4% |
| Dec 2025 | +17.0% |
| Sep 2025 | +14.9% |
| Jun 2025 | +13.2% |
| Mar 2025 | +14.1% |
| Dec 2024 | +17.6% |
| Sep 2024 | +15.4% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$354.3M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM MSA
| FY Dec 2025 | $295.4M |
| FY Dec 2024 | $242.2M |
| FY Dec 2023 | $50.1M |
| FY Dec 2022 | $114.9M |
| FY Dec 2021 | $155.3M |
| Jun 2026 | $82.7M |
| Mar 2026 | $65.1M |
| Dec 2025 | $106.0M |
| Sep 2025 | $100.5M |
| Jun 2025 | $37.9M |
| Mar 2025 | $51.0M |
| Dec 2024 | $93.5M |
| Sep 2024 | $70.1M |
At each fiscal year end
Single quarter
Debt to equity
0.43x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity MSA
| FY Dec 2025 | 0.42x |
| FY Dec 2024 | 0.44x |
| FY Dec 2023 | 0.62x |
| FY Dec 2022 | 0.62x |
| FY Dec 2021 | 0.72x |
| Jun 2026 | 0.43x |
| Mar 2026 | 0.45x |
| Dec 2025 | 0.42x |
| Sep 2025 | 0.48x |
| Jun 2025 | 0.54x |
| Mar 2025 | 0.42x |
| Dec 2024 | 0.44x |
| Sep 2024 | 0.51x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.68x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt MSA
| FY Dec 2025 | 0.63x |
| FY Dec 2024 | 0.58x |
| FY Dec 2023 | 0.15x |
| FY Dec 2022 | 0.27x |
| FY Dec 2021 | 0.33x |
| Jun 2026 | 0.68x |
| Mar 2026 | 0.62x |
| Dec 2025 | 0.63x |
| Sep 2025 | 0.56x |
| Jun 2025 | 0.47x |
| Mar 2025 | 0.61x |
| Dec 2024 | 0.58x |
| Sep 2024 | 0.63x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+23.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity MSA
| FY Dec 2025 | +22.2% |
| FY Dec 2024 | +27.0% |
| FY Dec 2023 | +6.2% |
| FY Dec 2022 | +20.4% |
| FY Dec 2021 | +2.6% |
| Jun 2026 | +23.7% |
| Mar 2026 | +22.8% |
| Dec 2025 | +22.2% |
| Sep 2025 | +23.4% |
| Jun 2025 | +24.2% |
| Mar 2025 | +26.2% |
| Dec 2024 | +27.0% |
| Sep 2024 | +27.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+12.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets MSA
| FY Dec 2025 | +11.7% |
| FY Dec 2024 | +13.0% |
| FY Dec 2023 | +2.6% |
| FY Dec 2022 | +7.5% |
| FY Dec 2021 | +1.0% |
| Jun 2026 | +12.2% |
| Mar 2026 | +12.1% |
| Dec 2025 | +11.7% |
| Sep 2025 | +11.7% |
| Jun 2025 | +11.6% |
| Mar 2025 | +13.0% |
| Dec 2024 | +13.0% |
| Sep 2024 | +12.3% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+18.0%
operating income after a 23.4% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital MSA
| FY Dec 2025 | +16.9% |
| FY Dec 2024 | +21.0% |
| FY Dec 2023 | n/a |
| FY Dec 2022 | +13.9% |
| FY Dec 2021 | +1.6% |
| Jun 2026 | +18.0% |
| Mar 2026 | +17.2% |
| Dec 2025 | +16.9% |
| Sep 2025 | +17.1% |
| Jun 2025 | +16.8% |
| Mar 2025 | +20.5% |
| Dec 2024 | +21.0% |
| Sep 2024 | +20.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+18.1%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed MSA
| FY Dec 2025 | +17.8% |
| FY Dec 2024 | +20.7% |
| FY Dec 2023 | +12.0% |
| FY Dec 2022 | +11.7% |
| FY Dec 2021 | +1.2% |
| Jun 2026 | +18.1% |
| Mar 2026 | +18.3% |
| Dec 2025 | +17.8% |
| Sep 2025 | +17.9% |
| Jun 2025 | +17.9% |
| Mar 2025 | +20.3% |
| Dec 2024 | +20.7% |
| Sep 2024 | +19.7% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
22.71x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing MSA
| FY Dec 2025 | 22.62x |
| FY Dec 2024 | 22.99x |
| FY Dec 2023 | 116.43x |
| FY Dec 2022 | 31.62x |
| FY Dec 2021 | 284.83x |
| Jun 2026 | 21.71x |
| Mar 2026 | 22.16x |
| Dec 2025 | 22.62x |
| Sep 2025 | 24.27x |
| Jun 2025 | 23.90x |
| Mar 2025 | 20.23x |
| Dec 2024 | 22.99x |
| Sep 2024 | 25.63x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$7.4B
market value at close 2026-10-26 on 2026-07-24 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value MSA
| FY Dec 2025 | $6.7B |
| FY Dec 2024 | $6.9B |
| FY Dec 2023 | $7.1B |
| FY Dec 2022 | $6.1B |
| FY Dec 2021 | $6.4B |
| Jun 2026 | $7.1B |
| Mar 2026 | $6.8B |
| Dec 2025 | $6.7B |
| Sep 2025 | $7.2B |
| Jun 2025 | $7.1B |
| Mar 2025 | $6.1B |
| Dec 2024 | $6.9B |
| Sep 2024 | $7.4B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+5.0%
TTM free cash flow over market value at close 2026-10-26
FCF yield MSA
| FY Dec 2025 | +4.7% |
| FY Dec 2024 | +3.7% |
| FY Dec 2023 | +0.8% |
| FY Dec 2022 | +2.0% |
| FY Dec 2021 | +2.6% |
| Jun 2026 | +5.3% |
| Mar 2026 | +4.9% |
| Dec 2025 | +4.7% |
| Sep 2025 | +4.2% |
| Jun 2025 | +3.8% |
| Mar 2025 | +4.4% |
| Dec 2024 | +3.7% |
| Sep 2024 | +4.2% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
1.55x
P/E over trailing EPS growth of 15%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing MSA
| FY Dec 2025 | n/a |
| FY Dec 2024 | 0.06x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | 0.04x |
| FY Dec 2021 | n/a |
| Jun 2026 | 1.48x |
| Mar 2026 | 10.71x |
| Dec 2025 | n/a |
| Sep 2025 | 9.88x |
| Jun 2025 | 12.65x |
| Mar 2025 | 2.73x |
| Dec 2024 | 0.06x |
| Sep 2024 | 0.03x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $1.9B | $1.8B | $1.8B | $1.5B |
| Gross profit | $871.1M | $860.4M | $852.1M | $673.8M |
| Operating income | $371.8M | $389.2M | $231.3M | $239.1M |
| Net income | $278.9M | $285.0M | $58.6M | $179.6M |
| EPS (diluted) | 7.09 | 7.21 | 1.48 | 4.56 |
| Operating cash flow | $363.9M | $296.4M | $92.9M | $157.5M |
| Cash | $165.1M | $164.6M | $146.4M | $162.9M |
| Long-term debt | $572.7M | $481.6M | $575.2M | $565.4M |
| Dividends paid | $82.3M | $78.8M | $73.5M | $71.5M |
SEC XBRL, fiscal years, as known on 2026-10-28
MSA Stock Sonar score 6/7 axes
Find similar shapesCompareMSA ranks highest on profitability (87th percentile) and institutional and government (86th), and lowest on growth (30th), among Medical Devices peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
MSA filings, in plain words
Are MSA Safety insiders buying or selling MSA?
In the 180 days to 2026-10-28, MSA Safety insiders were net sellers, a net $3.9M: $71.1K of purchases and $4.0M of sales reported on Form 4, by 1 buyer and 2 sellers.
Are there planned insider sales of MSA?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $4.5M of stock; the latest, by Howells David J, was filed 2026-08-18.
Read the full summary
In the 180 days to 2026-10-28, MSA Safety insiders were net sellers of MSA, a net $3.9M across purchases and sales reported on Form 4 by 1 buyer and 2 sellers. Sales outweighed purchases more than tenfold by value. Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $4.5M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
